Agenus Inc.
AGENBiotechnology
$7.09−0.56%As of Oct 29vs prior close
- Market cap
- $320.2M
- P/E (TTM)
- 2.3×
- P/E (FY1)
- 8.1×
- From 52W high
- −28.60%
- EPS (LTM)
- $3.04
- Revenue (LTM)
- $132.7M
- Net margin
- 69.18%
Nomior Score
58
Steady ProfileSpeculativeTop 30% of the scored universe
Growth50
Quality68
Value50
Momentum76
Resilience34
Growth
+19.74%revenue a year over 9 fiscal years
YE16 $22.6MLTM $132.7M
Connections
Revenue to profitQ2 YE26
The net loss was 2% of revenue, narrower by 107 pts on a year.
Who owns it
2funds